Any time I say hydralazine is trash a cardiologist slips into my DMs to defend. #NephJC I prefer to not torture patients if I can avoid it. (P.S. I love “whydralazine” 🤣)

I spy Dr. Ng! The best :)

The political effects of X's feed algorithm https://doi.org/10.1038/s41586-026-10098-2 Received: 16 December 2024 Accepted: 4 January 2026 Published online: 18 February 2026 Open access • Check for updates Germain Gauthier,5, Roland Hodler?5, Philine Widmer35 & Ekaterina Zhuravskaya3,4,5 m Feed algorithms are widely suspected to influence political attitudes. However, previous evidence from switching off the algorithm on Meta platforms found no political effects'. Here we present results from a 2023 field experiment on Elon Musk's platform X shedding light on this puzzle. We assigned active US-based users randomly to either an algorithmic or a chronological feed for 7 weeks, measuring political attitudes and online behaviour. Switching from a chronological to an algorithmic feed increased engagement and shifted political opinion towards more conservative positions, particularly regarding policy priorities, perceptions of criminal investigations into Donald Trump and views on the war in Ukraine. In contrast, switching from the algorithmic to the chronological feed had no comparable effects. Neither switching the algorithm on nor switching it off significantly affected affective polarization or self-reported partisanship. To investigate the mechanism, we analysed users' feed content and behaviour. We found that the algorithm promotes conservative content and demotes posts by traditional media. Exposure to algorithmic content leads users to follow conservative political activist accounts, which they continue to follow even after switching off the algorithm, helping explain the asymmetry in effects. These results suggest that initial exposure to X's algorithm has persistent effects on users' current political attitudes and account-following behaviour, even in the absence of a detectable effect on partisanship.

A new paper shows that less than 2 months of exposure to Twitter’s algorithmic feed significantly shifts people’s political views to the right.

Moving from chronological feed to the algorithmic feed also increases engagement.

This is one of the most concerning papers I’ve read in awhile.

I think there’s a lot of creative thinking that needs to happen to give *something* to reviewers. For example, many are affiliated with a professional organization so give me a membership discount and we can talk.. (those professional memberships are oof when you don’t have an academic stipend!!)

I had to get off all the other platforms because of doom scrolling.. Bluesky is my little safe nephrology haven 🤣

As for AI training - that’s happening everywhere. Some smart sounding people can be absolutely wrong in what they say, so let’s hope we aren’t training on perceived facts that are actually inaccurate. AI slop already plagues the platforms! (Sincerely, a pharmacist who can’t join Roon 🙃)

I think this is a bit too exposed for real, honest discourse. It will likely feel curated and by default inauthentic? I love the anonymous rage accounts that teach me a different, cynical perspective to healthcare..

I think a lot of us USC’s are just trying to hold on.. the optimism and “can do” attitude is fading as we all watch the atrocities and can’t afford basic needs. Makes chatting about GN superfluous when you’re just trying to survive 🤪 Probably why content is more and more passive..

The strides we’ve made in CKD are meaningful and they would not be possible without the care, expertise, and advocacy of pharmacists. Let’s carry that momentum forward and ensure we extend that same level of support to patients on dialysis, who deserve intentional, expert pharmaceutical care too 4/4

This complexity demands pharmacist involvement, yet structured pharmacy models in dialysis care remain sparse. Patients are often left to coordinate multiple medications across multiple prescribers without pharmacist support. 3/

Despite dialysis being one of the most vulnerable points in the kidney disease continuum, our profession still lacks well-established, standardized pharmacy services and systems dedicated to this population. 2/

There remains a significant and under-recognized gap in the care of dialysis patients. While CKD has seen tremendous developments, patients on dialysis continue to face highly complex medication regimens and impaired quality of life, much of which is exacerbated by medications themselves 1/ #NephSky

This Is How a Child Dies of Measles When your family becomes a data point in an outbreak

This is a vivid, horribly relevant read. “She does not sleep well. And as you lift up her pajama top to check her rash one morning, you see that her breathing is labored, shadows pooling between her ribs when she sucks in air. You suffer an icy moment of realization: This is a medical crisis.”

Agree flozins are generally low-risk, but without real, proven efficacy data am I just causing financial toxicity in an already strapped population? #NephJC

And unfortunately, we will suffer through years of retrospective reviews of single transplant center results (w/ a subsequent meta-analysis of questionable data) to say what we are doing is ok. Not to poke holes but it is the way in transplant. We need better trials for this niche population #NephJC

So true, and especially important when discussing culturally sensitive nutrition recommendations. Blanket avoidance of entire foods seems cruel, especially when it's a healthy, whole, easily accessible food like banana, beans, etc. It all seems more of a knee-jerk reaction vs. EBM #NephJC

Love to see this support! Couldn’t agree more that embedding pharmacists into clinics unlocks really well managed medication therapy, and often increases physician and APP satisfaction. It’s a team sport!

I love everything about this post because it’s SO true how complementary pharmacists are in a clinic setting!! Now go forth and preach the gospel to others!

Enjoyed working on this manuscript with several amazing pharmacist leaders! As nephrology continues its renaissance, pharmacists are key members of the care team. Pharmacist integration continues to evolve with many unique models and collaboration.

Or will a dialysis-centric mindset continue to dominate and this be left to wrap-around kidney care orgs with AI tech bros leading the charge? 😆

I've started to wonder if a "preventive nephrology" model will start to develop akin to cardiology.. as more awareness around progression risk takes off and (certain) patients are looking for lifestyle and risk reduction mods that PCPs can't provide..will neph move into this space?

In Gemini's defense, it was OpenEvidence that was misquoting things! But maybe that's even more scary because of the perceived, "This is associated with NEJM/JAMA/etc and cites sources and therefore is more trusted"..

Meanwhile, it's misquoting the guidelines and evidence and apologizing to me when I call it out.. I'm more worried how it will impact learners who just regurgitate the factually incorrect responses..

A part of me dies every time I see a baclofen RX from a nephrologist, especially when alternatives have not be trialed first.. #nephrology #pharmacy #justsayno

Our dark horse - fish oil! Too good to be true? But also pretty low risk.. I smell a (fishy) craze on the horizon similar to vitamin C in sepsis (remember when we all just started prescribing vitC+hydrocortisone+thiamine in the ICU without any questions?)

I'd like to believe that the AI will kill us all before it tanks the planet. It seems like the logical, AI-generated thing to do!

I think it’s important to note and thank the professional CDC staff that prepared such an exhaustive litany of information for the briefings that made clear that the decisions the “ACIP” voted on were actually counter to what the scientific evidence supported and was driven by their bias and animus

RAASi remain cornerstone therapies 🧩
Proven to slow CKD & cut CV risk ❤️ Still underused 🚫—mainly of hyperK⚡️
It’s time to use the RAASi toolkit! #NephSky #MedSky @theisn.org

Strange papers published by @asnpublications.bsky.social #K360

journals.lww.com/kidney360/ci...

Written by 3 pharma employees +2, first and corresponding author pharma employee, & ‘perspective’ says ……use the pharma product!

Why should *anyone* use calcefidiol aka OPKO pharma’s Rayaldee™️?

Follow the beans! (And not the kidney beans..)